SARS-CoV-2, also known as 2019 Novel Coronavirus, is a coronavirus identified as the cause of an outbreak of respiratory illness in Wuhan, China on 31 December 2019. Based on our extensive experience in drug discovery, Creative Biolabs has developed the unique platforms against the SARS-CoV-2.